Transplant tolerance in non-human primates: Progress, current challenges and unmet needs

被引:69
作者
Kean, LS
Gangappa, S
Pearson, TC
Larsen, CP [1 ]
机构
[1] Emory Univ, Sch Med, Dept Surg, Emory Transplant Ctr, Atlanta, GA 30322 USA
[2] Emory Univ, Sch Med, Dept Pediat, Div Hematol Oncol BMT, Atlanta, GA 30322 USA
[3] Childrens Healthcare Atlanta, Atlanta, GA USA
关键词
non-human primate; transplantation; tolerance;
D O I
10.1111/j.1600-6143.2006.01260.x
中图分类号
R61 [外科手术学];
学科分类号
摘要
Given the significant morbidity associated with current post-transplant immunosuppressive regimens, induction of immune tolerance continues to be an important goal of clinical organ transplantation. While many strategies for inducing tolerance have been successfully applied in murine models, significant barriers are faced when translating these approaches to the clinic. This has necessitated pre-clinical studies in the more closely related model system, the non-human primates (NHP). In this review, we will discuss the four most prominent strategies for inducing transplantation tolerance and highlight their relative success and shortcomings in NHP. These strategies are: (1) T-cell costimulation blockade (2) mixed chimerism induction (3) T-cell depletion and (4) tolerance induction through regulatory T-cells. After discussing the progress that has been made with each of these strategies, we will identify this field's most pressing unmet needs and discuss how we may best overcome the resulting barriers to tolerance induction.
引用
收藏
页码:884 / 893
页数:10
相关论文
共 95 条
[1]   Development of a chimeric anti-CD40 monoclonal antibody that synergizes with LEA29Y to prolong islet allograft survival [J].
Adams, AB ;
Shirasugi, N ;
Jones, TR ;
Durham, MM ;
Strobert, EA ;
Cowan, S ;
Rees, P ;
Hendrix, R ;
Price, K ;
Kenyon, NS ;
Hagerty, D ;
Townsend, R ;
Hollenbaugh, D ;
Pearson, TC ;
Larsen, CP .
JOURNAL OF IMMUNOLOGY, 2005, 174 (01) :542-550
[2]   Calcineurin inhibitor-free CD28 blockade-based protocol protects allogeneic islets in nonhuman primates [J].
Adams, AB ;
Shirasugi, N ;
Durham, MM ;
Strobert, E ;
Anderson, D ;
Rees, P ;
Cowan, S ;
Xu, HY ;
Blinder, Y ;
Cheung, M ;
Hollenbaugh, D ;
Kenyon, NS ;
Pearson, TC ;
Larsen, CP .
DIABETES, 2002, 51 (02) :265-270
[3]   Analysis of primate renal allografts after T-cell depletion with anti-CD3-CRM9 [J].
Armstrong, N ;
Buckley, P ;
Oberley, T ;
Fechner, J ;
Dong, YC ;
Hong, XN ;
Kirk, A ;
Neville, D ;
Knechtle, S .
TRANSPLANTATION, 1998, 66 (01) :5-13
[4]   Renal allograft rejection is prevented by adoptive transfer of anergic T cells in nonhuman primates [J].
Bashuda, H ;
Kimikawa, M ;
Seino, K ;
Kato, Y ;
Ono, F ;
Shimizu, A ;
Yagita, H ;
Teraoka, S ;
Okumura, K .
JOURNAL OF CLINICAL INVESTIGATION, 2005, 115 (07) :1896-1902
[5]   Treatment with humanized monoclonal antibodies against CD80 and CD86 combined with sirolimus prolongs renal allograft survival in cynomolgus monkeys [J].
Bîrsan, T ;
Hausen, B ;
Higgins, JP ;
Hubble, RW ;
Klupp, J ;
Stalder, M ;
Celniker, A ;
Friedrich, S ;
O'Hara, RM ;
Morris, RE .
TRANSPLANTATION, 2003, 75 (12) :2106-2113
[6]   CD28 function: A balance of costimulatory and regulatory signals [J].
Bour-Jordan, H ;
Bluestone, JA .
JOURNAL OF CLINICAL IMMUNOLOGY, 2002, 22 (01) :1-7
[7]   A THEORY OF SELF-NONSELF DISCRIMINATION [J].
BRETSCHER, P ;
COHN, M .
SCIENCE, 1970, 169 (3950) :1042-+
[8]  
Brouha PCR, 2001, TRANSPLANTATION, V72, pS36
[9]   Anti-CD154 monoclonal antibody and thromboembolism [J].
Buhler, L ;
Alwayn, IPJ ;
Appel, JZ ;
Robson, SC ;
Cooper, DKC .
TRANSPLANTATION, 2001, 71 (03) :491-491
[10]   Induction of kidney allograft tolerance after transient lymphohematopoietic chimerism in patients with multiple myeloma and end-stage renal disease [J].
Bühler, LH ;
Spitzer, TR ;
Sykes, M ;
Sachs, DH ;
Delmonico, FL ;
Tolkoff-Rubin, N ;
Saidman, SL ;
Sackstein, R ;
McAfee, S ;
Dey, B ;
Colby, C ;
Cosimi, AB .
TRANSPLANTATION, 2002, 74 (10) :1405-1409